These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10329869)

  • 1. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia.
    van Pampus MG; Dekker GA; Wolf H; Huijgens PC; Koopman MM; von Blomberg BM; Büller HR
    Am J Obstet Gynecol; 1999 May; 180(5):1146-50. PubMed ID: 10329869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy.
    Ganzevoort W; Rep A; De Vries JI; Bonsel GJ; Wolf H;
    Hypertens Pregnancy; 2007; 26(4):433-45. PubMed ID: 18066962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underlying disorders associated with severe early-onset preeclampsia.
    Dekker GA; de Vries JI; Doelitzsch PM; Huijgens PC; von Blomberg BM; Jakobs C; van Geijn HP
    Am J Obstet Gynecol; 1995 Oct; 173(4):1042-8. PubMed ID: 7485291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia.
    Lee RM; Brown MA; Branch DW; Ward K; Silver RM
    Obstet Gynecol; 2003 Aug; 102(2):294-300. PubMed ID: 12907102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies.
    Mello G; Parretti E; Martini E; Mecacci F; La Torre P; Cioni R; Lucchetti R; Fedi S; Gori AM; Pepe G; Prisco D; Abbate R
    Haemostasis; 1999; 29(4):197-203. PubMed ID: 10702700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies in women at risk for preeclampsia.
    Branch DW; Porter TF; Rittenhouse L; Caritis S; Sibai B; Hogg B; Lindheimer MD; Klebanoff M; MacPherson C; VanDorsten JP; Landon M; Paul R; Miodovnik M; Meis P; Thurnau G;
    Am J Obstet Gynecol; 2001 Apr; 184(5):825-32; discussion 832-4. PubMed ID: 11303189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HELLP syndrome and factor V Leiden.
    Bozzo M; Carpani G; Leo L; Marcozzi S; Sacchi E; Moroni G; Pardi G
    Eur J Obstet Gynecol Reprod Biol; 2001 Mar; 95(1):55-8. PubMed ID: 11267721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome.
    Gul A; Cebeci A; Aslan H; Polat I; Ozdemir A; Ceylan Y
    Gynecol Obstet Invest; 2005; 59(2):113-8. PubMed ID: 15591806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between phenotypes of preeclampsia and thrombophilia.
    Berks D; Duvekot JJ; Basalan H; De Maat MP; Steegers EA; Visser W
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():199-205. PubMed ID: 26444331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin antibodies and the severity of preeclampsia-eclampsia.
    Martínez-Abundis E; González-Ortiz M; Cortés-Llamas V; Salazar-Páramo M
    Gynecol Obstet Invest; 1999; 48(3):168-71. PubMed ID: 10545739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent hemodynamic abnormalities in symptom-free women with a history of preeclampsia.
    Spaanderman ME; Ekhart TH; van Eyck J; Cheriex EC; de Leeuw PW; Peeters LL
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):101-7. PubMed ID: 10649163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preeclampsia is associated with a reduced response to activated protein C.
    Lindoff C; Ingemarsson I; Martinsson G; Segelmark M; Thysell H; Astedt B
    Am J Obstet Gynecol; 1997 Feb; 176(2):457-60. PubMed ID: 9065198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perinatal mortality and preeclampsia/eclampsia: influence of HELLP syndrome on the primigravida].
    Van Bogaert LJ
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):323-6. PubMed ID: 7622782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there any effect of tumor burden on hemostatic parameters in cancer patients? A case-control study of hemostatic abnormalities and anticardiolipin antibodies in solid tumors.
    Turna H; Ozguroglu M; Bolayirli M; Orhanoglu T; Balci H
    Clin Appl Thromb Hemost; 2009; 15(4):454-7. PubMed ID: 18160567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fatal complications in pre-eclampsia and eclampsia].
    Srp B; Velebil P; Kvasnicka J
    Ceska Gynekol; 2002 Nov; 67(6):365-71. PubMed ID: 12661377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia.
    Perry KG; Martin JN
    Clin Obstet Gynecol; 1992 Jun; 35(2):338-50. PubMed ID: 1638825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin 20210 G: a mutation and Factor V Leiden mutation in women with a history of severe preeclampsia and (H)ELLP syndrome.
    van Pampus MG; Wolf H; Koopman MM; van den Ende A; Buller HR; Reitsma PH
    Hypertens Pregnancy; 2001; 20(3):291-8. PubMed ID: 12044337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The factor V Leiden mutation may predispose women to severe preeclampsia.
    Dizon-Townson DS; Nelson LM; Easton K; Ward K
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):902-5. PubMed ID: 8885745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical usefulness of antiphospholipid and anticofactor antibodies in different Spanish preeclampsia subsets.
    Ferrer-Oliveras R; Llurba E; Cabero-Roura L; Alijotas-Reig J
    Lupus; 2012 Mar; 21(3):257-63. PubMed ID: 22065091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular reactivity in patients with preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.
    Fischer T; Schneider MP; Schobel HP; Heusser K; Langenfeld M; Schmieder RE
    Am J Obstet Gynecol; 2000 Dec; 183(6):1489-94. PubMed ID: 11120516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.